Abstract
2-Chloro-N6-cyclopentyladenosine (CCPA) was synthesized as a potential
high affinity ligand for A1 adenosine receptors. Binding of 3HPIA
to A1 receptors of rat brain membranes was inhibited by CCPA with
a Ki-value of 0.4 nM, compared to a Ki-value of 0.8 nM for the parent
compound N6-cyclopentyladenosine (CPA). Binding of 3HNECA to A2
receptors of rat striatal membranes was inhibited with a Ki-value
of 3900 nM, demonstrating an almost 10,000-fold A1-selectivity of
CCPA. CCPA inhibited the activity of rat fat cell membrane adenylate
cyclase, a model for the A1 receptor, with an IC50-value of 33 nM,
and it stimulated the adenylate cyclase activity of human platelet
membranes with an EC50-value of 3500 nM. The more than 100-fold A1-selectivity
compares favourably with a 38-fold selectivity of CPA. Thus, CCPA
is an agonist at A1 adenosine receptors with a 4-fold higher selectivity
and 2-fold higher affinity than CPA, and a considerably higher selectivity
than the standard A1 receptor agonist R-N6-phenylisopropyladenosine
(R-PIA). CCPA represents the agonist with the highest selectivity
for A1 receptors reported so far.
Users
Please
log in to take part in the discussion (add own reviews or comments).